Posted by Michael Wonder on 08 Dec 2017
New deal will give people with kidney cancer another treatment option
8 December 2017 - People with advanced kidney cancer are set to benefit from a new treatment, after NICE has said lenvatinib should be available on the NHS.
NICE recommends lenvatinib, also known as Kisplyx, be given in conjunction with another drug called everolimus.
This drug-duo is recommended as an option for people who have previously been treated for advanced renal cell carcinoma.
